-
30 years of new breakthrough! The first immuno-tumor drug to treat pee path cancer in China has been approved.
Time of Update: 2020-08-18
Interviewed experts: He Zhixuan, Deputy Director of the Institute of Urology, Peking University, Peking University, The First Hospital, Director of Urology, Professor specializes in treatment: urolog
-
Novartis Tumor 8 new special drugs shortlisted for China's first provincial-level special drug insurance.
Time of Update: 2020-08-18
"Lecheng Global Special Drug Insurance" is the first area of Lecheng to achieve the "three synchronization" of drugs and international advanced level of the development of health insurance innovation products, aimed at reducing the medical burden of low- and middle-income families in the country through commercial insurance to enable the global innovative drugs can more widely benefit Chinese patients.
-
Roche launches a special program for the combination of digestive tract tumor immunotherapy.
Time of Update: 2020-08-18
On July 6, Roche Pharmaceuticals China announced that it will officially launch a special program dedicated to China's "Joint TherapeuticSis Cooperation in Digestive Tract Tumors" for China, which will support innovative Chinese companies in the development of new therapies for digestive tract tumors, and provide a variety of support including funding, free research drugs and research and development strategies.
-
Gynaecological tumor big curry road ovarian cancer diagnosis and treatment.
Time of Update: 2020-08-18
Saturday, June 6, from 14:00 to 17:00 p.m., the People's Daily Health Client and the People's Daily Health Times invited a number of domestic mastodons to focus on the front-line progress in the diagnosis and treatment of ovarian cancer in the form of a live webcast.
-
To help the balanced development of regional medical care, tumor minimally invasive technology promotion project landed in Qinghai.
Time of Update: 2020-08-18
Zhang Chengwu vice-president said that the project actively respond to the national graded diagnosis and treatment and the specific implementation of the construction of the medical union, as a cancer diagnosis and treatment center in Qinghai Province, Qinghai University Hospital will improve the basic medical staff of the standardized treatment of tumors, in the minimally invasive treatment to achieve standardization.
-
3 kg of malignant tumor filled the left chest cavity, the full excision of less than 100 ml of bleeding.
Time of Update: 2020-08-18
After the department research and discussion, the use of minimally invasive or side incision can not completely remove the tumor, thoracic surgery Ye Qing director of the doctor decided to use the positive chest open for the patient "bounce." Prior to the operation, the team had a detailed communication with Ms. Jiang and her family to carefully design the details that might be encountered during each operation.
-
Swimming instructor Xu Guoyi died, and the tumor proliferated quickly and 100 percent would recur.
Time of Update: 2020-08-18
Interviewed experts: Wang Jin, Vice President of Tsinghua Changxuan Hospital, Beijing, Chief Medical Physician good at: a variety of brain and spinal spinal lesions, brain tumors, gliomas, such as comprehensive treatment, good at tumor stereotactic surgery biopsy, minimally invasive damage surgery, deep brain electrodes (Parkinson's disease, Tremors, dystonia, epilepsy, pain, Tourette's syndrome, depression) : Tuesday morning, Thursday morning (Health Times reporter Mao Yuan) swimming pool pain loss!
-
A strategy for the treatment of gastrointestinal tumors.
Time of Update: 2020-08-18
The incidence and mortality rate of gastrointestinal tumorinis in China are serious, and the incidence and mortality of stomach cancer, liver cancer, colorectal cancer and esophageal cancer are among
-
The analysis of blood tumor treatment is the most preferred.
Time of Update: 2020-08-18
On Friday, April 17, from 17:30 to 18:30 p.m., the top tumor names in the National Cancer Prevention and Prevention Publicity Week series of "People's Famous Medical" live-streamed the second session, inviting the Beijing Heathcote Foundation Supervisor, The Chinese Society of Clinical Oncology (CSCO) And Ma Jun, director of the Harbin Institute of Blood Diseases, to provide you with the best choice for blood cancer treatment.
-
To improve the "winning rate" of anti-cancer disease, Zhongshan cancer team nasopharyngeal cancer dynamic prognosis index made new progress.
Time of Update: 2020-08-17
Experts: Sun Ying Sun Ying Sun Ying, Vice President of the Cancer Prevention center, Vice President of the Youth Committee of the China Anti-Cancer Association, Vice Chairman of the Youth Committee o
-
Rare in the world, tumors grow from the abdominal cavity into the heart! The 6-hour "relay" operation was successfully removed.
Time of Update: 2020-08-17
. The rare huge swelling in the heart "occupying" the right atrium up to 90% it is understood that six months ago, Ms. Ding appeared under the abdominal swelling pain, recently, Ms. Ding in the morning stool after sudden dizziness, breathing difficulties, the local county hospital diagnosis prompted the cavity veins high echo, consider the possibility of tumor thrombosis, recommended to the Central South University Xiangya II Hospital.
-
To provide direction for the development of anti-tumor drugs, the Chinese team has identified new potential targets for lung cancer treatment.
Time of Update: 2020-08-17
recently, Fudan University School of Pharmacy Zhou Wei team teamed up with Shanghai Jiaotong University School of Medicine Shen Wei group and Shanghai University of Traditional Chinese Medicine Chen Hong special group found that the new phosphate glycolic acid variant enzyme 1 (PGAM1) non-structural inhibitors have a inhibitory effect on the proliferation and metastasis of non-small cell lung cancer.
-
Professor Li Jin: China's cancer innovation drug research and development, their own things to do their own!
Time of Update: 2020-08-17
(Health Times Media Group Wen Wei Yu Jiali Yang Qiuyu) " In developed countries in Europe and the United States, research focuses on their own areas of high-risk cancer, such as breast cancer, lung cancer, prostate cancer, so in these areas out of a lot of new drugs, but China's high incidence of cancer such as liver cancer, stomach cancer, esophageal cancer, thyroid cancer is relatively low attention.
-
When the famous medical consultation is carried out, the question and answer of the breast tumor treatment.
Time of Update: 2020-08-17
sweep the two-dimensional code above into the Health Times WeChat Live Room, watch the live broadcast and ask questions online.
-
Tumor prevention and treatment, to make up the grass-roots short board.
Time of Update: 2020-08-17
Wang Yi Zhao Ping, director of the Medical Resources Department of the National Health and Construction Commission of the , said that the cancer treatment capacity of Chinese county hospitals is still difficult to cope with the needs of most rural patients.
-
With annual sales of nearly $2 billion, AstraZeneca's cancer star drug New Indications is about to be approved.
Time of Update: 2020-08-17
Recently, the drug network database shows that AstraZeneca submitted Ohitini's second new indication", "first-line treatment for epidermal growth factor receptor (EGFR) gene mutation of advanced non-small cell lung cancer (NSCLC) patients" listing application, has entered the "in approval" state, will soon be approved for listing.
-
Gynaecological oncology prevention and treatment question and answer.
Time of Update: 2020-08-17
On Thursday, September 26th, from 15:00 to 16:00 p.m., Professor Wu Lingying, director of the department of obstetrics and gynecology at the Oncology Hospital of the Chinese Academy of Medical Sciences, will be a guest in the "People's Famous Medical" live room to help young women ring the alarm again.
-
Biomedicine entered the 3.0 era, the first CSCO-Ding Oncology Summit Forum was held in Beijing.
Time of Update: 2020-08-17
"In recent years, the innovation ability of China's biopharmaceutical industry has been greatly enhanced, and biomedicine has entered the 3.0 era of open innovation, which provides new opportunities for the development of China's oncology sector." Professor Li Jin, chairman of the Chinese Society of Clinical Oncology (CSCO) and affiliated with Tongji University Oriental Hospital, said.
-
Breast tumor prevention and treatment question and answer.
Time of Update: 2020-08-17
October is breast cancer prevention and control month, the People's Daily Health Times "People's Famous Medical" special planning breast cancer prevention and control publicity special live broadcast, invited one of China's leading leaders in breast cancer prevention and control, the Chinese Society of Clinical Oncology (CSCO) Vice President, plass General Hospital Fifth Medical Center (formerly PLA 307 Hospital) breast oncology director Professor Jiang Zefei, and interactive sharing of breast cancer prevention and control knowledge.
-
Gynaecological tumor prevention and treatment answer questions.
Time of Update: 2020-08-17
the "People's Famous Medical" to watch and ask questions as follows: sweep the two-dimensional code above to enter the Health Times WeChat live room, watch the live broadcast and online questions.
